TherapeuticsMD (TXMD) Profit After Tax (2010 - 2026)

TherapeuticsMD has reported Profit After Tax for 17 years, with the latest figure at $103000.0 in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 115.77% year-over-year to $103000.0; the trailing twelve-month figure through Mar 2026 stood at $1000.0 (up 100.05% YoY), and the FY2025 full-year result was -$653000.0, up 70.06% from the prior year.
• Profit After Tax for Q1 2026 stood at $103000.0, up from -$703000.0 in the prior quarter.
• The five-year high for Profit After Tax was $112.3 million in Q2 2022, with the low at -$49.0 million in Q1 2022.
• Historically, Profit After Tax has averaged -$439941.2 across 5 years, with a median of -$703000.0 in 2025.
• Annual changes were most pronounced in 2022 — Profit After Tax surged 363.25% — and 2025, when it sank 386.94%.
• TherapeuticsMD's Profit After Tax stood at -$33.2 million in 2022, then soared by 105.11% to $1.7 million in 2023, then plunged by 85.55% to $245000.0 in 2024, then slumped by 386.94% to -$703000.0 in 2025, then soared by 114.65% to $103000.0 in 2026.
• The last three Profit After Tax figures came in at $103000.0 (Q1 2026), -$703000.0 (Q4 2025), and $50000.0 (Q3 2025), per Business Quant data.